Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Promoter methylations of RASSF1A and p16 is associated with clinicopathological features in lung cancers.

Journal of cancer research and therapeutics - 1 Jan 2000

Han Ji-Chang, Xu Feng, Chen Na, Qi Guan-Bin, Wei Yu-Ju, Li Hong-Bing, Zhang Yi-Jie, Li Jing-He, Wang Xiu-Li, Xu Wen, Li Xiao-Feng, Jin Li-Fang, Jia Jiao-Yuan, Ma Zhong-Sen

Abstract excerpt

UNLABELLED: Objection: The aim of this study is to investigate the association between promoter methylation of RASSF1A and p16 and the clinicopathological features in lung cancers. MATERIALS AND METHODS: PubMed, EBSCO, Ovid, Wiley, Web of Science, Wanfang, and VIP databases were searched using combinations of keywords related to RASSF1A, p16, methylation, and lung cancers. After screening for relevant studies,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Squamous Cell

Share to Cyclin-Dependent Kinase Inhibitor p16

Share to DNA Methylation

Share to Early Detection of Cancer

Share to Neoplasm Proteins

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 27072261
DOI: 10.4103/0973-1482.154926

Genes

VIP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Promoter methylations of RASSF1A and p16 is associated with clinicopathological features in lung cancers.PMID 27072261Read ↗

Association of RASSF1A promoter methylation with lung cancer risk: a meta-analysis.Semantic proximity Read ↗

Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood.Semantic proximity Read ↗

Quantitative promoter hypermethylation analysis of RASSF1A in lung cancer: comparison with methylation-specific PCR technique and clinical significance.Semantic proximity Read ↗

Inverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: relation with smoking status.Semantic proximity Read ↗

Role of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studies.Semantic proximity Read ↗

The relationship between RASSF1A promoter methylation and thyroid carcinoma: A meta-analysis of 14 articles and a bioinformatics of 2 databases (PRISMA).Semantic proximity Read ↗

Aberrant Promoter Methylation Profile and Association with Survival in Patients with Non–Small Cell Lung CancerSemantic proximity Read ↗

Association between Ras association domain family 1A promoter methylation and esophageal squamous cell carcinoma: a meta-analysis.Semantic proximity Read ↗

P16INK4a gene promoter methylation as a biomarker for the diagnosis of non‐small cell lung cancer: An updated meta‐analysisSemantic proximity Read ↗

O-6-methylguanine-DNA methyltransferase gene promoter methylation and lung cancer risk: A meta-analysis.Semantic proximity Read ↗

Hypermethylation of p16INK4a in Chinese lung cancer patients: biological and clinical implicationsSemantic proximity Read ↗

The role of DNA methylation and DNA methyltransferases (DNMTs) as potential biomarker and therapeutic target in non-small cell lung cancer (NSCLC)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.